Showing results (721-730 of 794) with videos related to
Sort By:
Pageof 80
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.The Journal of Clinical Investigation|June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5DKazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.The Journal of Clinical Investigation|March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancerLarissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.Science Advances|September 16, 2020
The fungal collaboration gradient dominates the root economics space in plantsJoana Bergmann, Alexandra Weigelt, Fons van der Plas, et al.Cancers|January 11, 2024
Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid TumorsLan Zheng, Rajyalakshmi Luthra, Hector A Alvarez, et al.Nature Medicine|April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profilesPaloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.Pageof 80